Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
130.11B
Market cap130.11B
Price-Earnings ratio
14.42
Price-Earnings ratio14.42
Dividend yield
3.83%
Dividend yield3.83%
Average volume
14.95M
Average volume14.95M
High today
$63.98
High today$63.98
Low today
$63.00
Low today$63.00
Open price
$63.56
Open price$63.56
Volume
1.84M
Volume1.84M
52 Week high
$68.10
52 Week high$68.10
52 Week low
$42.52
52 Week low$42.52

Stock Snapshot

Bristol-Myers Squibb(BMY) stock is priced at $63.70, giving the company a market capitalization of 130.11B. It carries a P/E multiple of 14.42 and pays a dividend yield of 3.83%.

During the trading session on 2026-08-12, Bristol-Myers Squibb(BMY) shares reached a daily high of $63.98 and a low of $63.00. At a current price of $63.70, the stock is +1.1% higher than the low and still -0.4% under the high.

Trading activity shows a volume of 1.84M, compared to an average daily volume of 14.95M.

The stock's 52-week range extends from a low of $42.52 to a high of $68.10.

The stock's 52-week range extends from a low of $42.52 to a high of $68.10.

BMY News

Nasdaq 1d
November 20th Options Now Available For Bristol Myers Squibb

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options become available today, for the November 20th expiration. One of the key inputs that goes in...

November 20th Options Now Available For Bristol Myers Squibb
Simply Wall St 1d
Is Schrödinger Undervalued Following Its Profit Turn And Bristol Myers Squibb Deal? - simplywall.st

...

Is Schrödinger Undervalued Following Its Profit Turn And Bristol Myers Squibb Deal? - simplywall.st
Simply Wall St 6d
Bristol Myers Squibb Stock Looks Reasonable Below Fair Value

Bristol-Myers Squibb stock has delivered a 48.8% return over the past year, yet current checks still point to a company that screens as undervalued on both intr...

Bristol Myers Squibb Stock Looks Reasonable Below Fair Value

Analyst ratings

61%

of 31 ratings
Buy
35.5%
Hold
61.3%
Sell
3.2%

More BMY News

TipRanks 7d
Midday Fly By: SpaceX slips, Disney reports earnings beat

The major averages were mixed near noon, with the Dow up nearly 400 points as investors weigh another wave of corporate earnings against continued geopolitical...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.